Cardiogenic Shock Classification
Cardiogenic shock should be classified using the SCAI (Society for Cardiovascular Angiography and Interventions) staging system, which stratifies patients into five progressive stages (A through E) based on physical examination findings, biochemical markers, and hemodynamics. 1, 2
The SCAI Classification System
The SCAI classification provides a standardized framework endorsed by ACC, AHA, SCCM, and STS that directly correlates with mortality risk and guides treatment intensity 3:
Stage A - At Risk
- No current signs or symptoms of cardiogenic shock
- Patients at risk for development of shock
- Includes those with:
- Large acute myocardial infarction
- Prior infarction with acute or acute-on-chronic heart failure symptoms
- Mortality: 3.0-14.3% 4, 5
Stage B - Beginning Cardiogenic Shock
- Clinical evidence of relative hypotension OR tachycardia WITHOUT hypoperfusion
- Hemodynamic compromise present but tissue perfusion maintained
- Mortality: 7.1-20.9% 4, 5
Stage C - Classic Cardiogenic Shock
- Hypoperfusion requiring intervention beyond volume resuscitation
- Requires inotropes, pressors, or mechanical support (including ECMO)
- Typically presents with relative hypotension
- Mortality: 12.4-32.7% 4, 6
Stage D - Deteriorating/Doom
- Similar to Stage C but worsening despite initial interventions
- Failure to respond after at least 30 minutes of observation and treatment 3
- Mortality: 32.7-67.9% 4, 6
Stage E - Extremis
- Cardiac arrest with ongoing CPR and/or ECMO
- Supported by multiple interventions simultaneously
- Refractory circulatory collapse
- Mortality: 44.8-67.0% 4, 5
Updated SCAI-CSWG Criteria (2022)
The Cardiogenic Shock Working Group refined the original SCAI classification with specific objective parameters to better define hypotension and hypoperfusion 7, 5:
Key Defining Parameters:
- Hypotension: Systolic blood pressure <90 mmHg or mean arterial pressure <65 mmHg
- Hypoperfusion markers:
- Lactate elevation (2-5 mEq/L for Stage B; >5 mEq/L for higher stages)
- Elevated alanine transaminase (hepatic injury)
- Systemic acidosis (pH)
- Acute kidney injury
Clinical Application and Prognostic Value
The SCAI classification demonstrates consistent, reproducible graded association between shock severity and mortality across diverse populations 8:
- Validated in cardiac intensive care units with 10,004 patients 4
- Predictive regardless of etiology (acute MI vs. heart failure) 4
- Each higher stage independently associated with increased mortality (adjusted OR: 1.53-6.80) 4
- Presence of cardiac arrest further increases mortality risk (adjusted OR: 3.99) 4
Dynamic Assessment is Critical:
- Both baseline AND maximum SCAI stage during hospitalization predict mortality 7
- Lower baseline stage associated with higher incidence of stage escalation 7
- Continuous reassessment throughout hospitalization is essential 8
Predictors of Clinical Deterioration
In Stage B patients, acute kidney injury and diuretic resistance independently predict progression to higher stages 9:
- Acute kidney injury: adjusted OR 2.17 (95% CI 1.11-4.22)
- Diuretic resistance: adjusted OR 9.55 (95% CI 2.61-34.89)
- Isolated hypotension carries worse prognosis than isolated hypoperfusion 9
Alternative Classification Systems
While the SCAI system is the primary guideline-endorsed classification 1, other approaches exist 10:
- Hemodynamic classification: Based on peripheral circulation (warm/cold) and volume status (wet/dry)
- Machine learning-based clusters: Non-congested, cardiorenal, and cardiometabolic shock 10
However, the SCAI system remains the standard for clinical practice and research given its widespread validation and endorsement by major cardiovascular societies 3, 11.
Treatment Implications by Stage
Treatment intensity should escalate with SCAI stage 12:
- Stage A-B: Optimize medical therapy, close monitoring
- Stage C: Consider inotropes/pressors, evaluate for mechanical circulatory support
- Stage D-E: Multidisciplinary shock team activation, mechanical circulatory support, consider advanced therapies
The classification facilitates standardized communication among multidisciplinary teams and enables risk-stratified treatment algorithms 11.